| Literature DB >> 16548918 |
S Mittal1, B J Milner, P W Johnston, D J Culligan.
Abstract
Hepatosplenic gamma-delta T-cell lymphoma is a rare, usually fatal lymphoma and available literature on management is sparse. Allografting is probably the only curative option. We describe a further case with a dramatic, though transient response to Fludarabine and Alemtuzumab combination, following a failure of conventional chemotherapy. Given the dreadful prognosis with conventional chemotherapy, it is a regimen worth pursuing as a disease reduction strategy prior to allograft where appropriate.Entities:
Mesh：
Substances：
Year: 2006 PMID： 16548918 DOI： 10.1111/j.1600-0609.2006.00646.x
Source DB: PubMed Journal: Eur J Haematol ISSN： 0902-4441 Impact factor: 2.997